TRY NOW

Enhance and accelerate your early stage research with trusted and comprehensive intelligence from Thomson Reuters.

Start your free trial in just two simple steps.

Get your FREE trial

Enrich your discovery science with market leading, manually curated scientific intelligence. Systems Biology, Preclinical, Biomarkers, Chemistry, Biology, and Pharmacology - and everything in between. Covered from the perspective that matters most – yours.
Customer Feedback
Customer Feedback

Annette Bakker, Chief Scientific Officer from CTF, explains the reasons why she likes to work with Thomson Reuters. Currently using MetaCore™ to identify disease treatment options.

Live & Recorded Training

Attend one of our regularly scheduled webinar training sessions for overviews of features, tools, and content – find the schedule here

Free Pathway Maps

Search or browse through a wide range of proprietary multi-step canonical pathway maps here.

Featured News

The latest news from Life Sciences Research
The future of COPD treatment

The future of COPD treatment

Our research shows greater focus on preventative therapies

Translational Medicine

Translational Medicine

Supplement-Size Doses of Antioxidants Hasten Lung Cancer Progression

Tet Proteins Erase Epigenetic Marks

Tet Proteins Erase Epigenetic Marks

It is (reasonably) common knowledge that DNA is written in a simple four-letter code: ACTG. Too simple, actually.

Blog Highlights

Read our latest blog posts

Overcoming Clinical Challenges in China

If forecasts are correct, china will become the second largest pharmaceutical market in the world in 2017, overtaking Japan. With an annual increase in the ...

Video: Therapeutic Proteins International’s CEO Dispels the Myths of Biosimilars

Sarfaraz K. Niazi, founder, chairman and CEO, Therapeutic Proteins International, explained to BioWorld how TPI is developing biosimilars without the need for expensive clinical trials. ...

Six Considerations when Developing a Competitive Biosimilar Strategy in a Challenging Landscape

Biopharmaceuticals (biologics) the most lucrative drugs on the market have revolutionized the business and practice of medicine. In 2012, seven of the top 10 best ...

Whitepapers & Publications

View our recent whitepapers and publications

BioMarker White Paper

White paper establishing the standards in biomarker research.

Thomson Reuters Professional Services White Paper

Knowledge-Based Drug Repositioning to Drive R&D Productivity

Thomson Reuters Professional Services Report

The economic power of orphan drugs

Latest on Twitter

Latest on Linked In